Literature DB >> 16442984

Self-reported treatments used for lower-limb phantom pain: descriptive findings.

Marisol A Hanley1, Dawn M Ehde, Kellye M Campbell, Bridget Osborn, Douglas G Smith.   

Abstract

OBJECTIVE: To examine the types and relative frequency of treatments used for lower-limb phantom limb pain (PLP), including both pharmacologic and rehabilitative interventions.
DESIGN: Cross-sectional survey.
SETTING: Community-based survey from clinical databases. PARTICIPANTS: Community-based sample (N=255) of persons with lower-limb amputations.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Intensity of PLP and type and helpfulness of treatments (both past and present) used for PLP.
RESULTS: Although 72% of the sample (n=183) reported current PLP, 53% of the respondents with PLP (and 38% of those with severe PLP) had never used treatment for PLP. Those who had used treatment reported greater pain severity and interference. The most commonly used treatment modality was analgesic medication, including acetaminophen, opioids, and nonsteroidal anti-inflammatory drugs. Of the treatments surveyed, only opioids and chiropractic care were rated as moderately to extremely helpful by the majority of those who had tried them, and many pain interventions had been discontinued.
CONCLUSIONS: As hypothesized, a significant proportion of persons with PLP have not used treatment for this pain, and, among those who have used pain treatments, few treatments are perceived as substantially helpful. More research is needed to identify effective management strategies for PLP and to examine further patient perceptions of pain treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16442984     DOI: 10.1016/j.apmr.2005.04.025

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  15 in total

1.  Utilization and patients' perceptions of the effectiveness of pain treatments in multiple sclerosis: A cross-sectional survey.

Authors:  Dawn M Ehde; Kevin N Alschuler; Travis L Osborne; Marisol A Hanley; Mark P Jensen; George H Kraft
Journal:  Disabil Health J       Date:  2015-03-14       Impact factor: 2.554

Review 2.  Coping with Phantom Limb Pain.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

3.  Body representation among adults with phantom limb pain: Results from a foot identification task.

Authors:  Emma H Beisheim-Ryan; Ryan T Pohlig; Jared Medina; Gregory E Hicks; Jaclyn M Sions
Journal:  Eur J Pain       Date:  2021-09-17       Impact factor: 3.931

4.  [Prolonged-release tapentadol for phantom pain. A case series].

Authors:  K-U Kern; P Bialas; D Fangmann
Journal:  Schmerz       Date:  2013-04       Impact factor: 1.107

5.  Chronic pain associated with upper-limb loss.

Authors:  Marisol A Hanley; Dawn M Ehde; Mark Jensen; Joseph Czerniecki; Douglas G Smith; Lawrence R Robinson
Journal:  Am J Phys Med Rehabil       Date:  2009-09       Impact factor: 2.159

6.  [Prevalence and risk factors of phantom limb pain and phantom limb sensations in Germany. A nationwide field survey].

Authors:  U Kern; V Busch; M Rockland; M Kohl; F Birklein
Journal:  Schmerz       Date:  2009-10       Impact factor: 1.107

7.  Self-Reported Cognitive Concerns in People With Lower Limb Loss.

Authors:  Sara J Morgan; Valerie E Kelly; Dagmar Amtmann; Rana Salem; Brian J Hafner
Journal:  Arch Phys Med Rehabil       Date:  2016-02-01       Impact factor: 3.966

8.  Auricular Therapy for Treating Phantom Limb Pain Accompanied by Jumping Residual Limb: A Short Review and Case Study.

Authors:  Hongfang Tian; Hantong Hu; Xingling Li; Jing Liu; Qin Guo; Yang Li; Dexiong Han
Journal:  Pain Ther       Date:  2021-03-04

9.  Phantom limb pain: mechanisms and treatment approaches.

Authors:  Bishnu Subedi; George T Grossberg
Journal:  Pain Res Treat       Date:  2011-08-14

10.  Electroacupuncture For Alleviation Of Phantom Limb Pain.

Authors:  Holly King; Max Forrester
Journal:  J Rehabil Med Clin Commun       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.